Laboratory controls do not include the establishment of scientifically sound and appropriate specifications, standards and test procedures designed to assure that in-process materials and drug products conform to appropriate standards of identity, strength, quality and purity.
Inspection Record
Blossom Pharmaceuticals — FDA 483 Findings
Inspectors Kellia N HicksThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Equipment and utensils are not cleaned, maintained and sanitized at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.
The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
Employees are not given training in the particular operations they perform as part of their function and current good manufacturing practices.
Written procedures are not established and followed for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Written production and process control procedures are not followed in the execution of production and process control functions and documented at the time of performance.
Buildings used in the manufacture, processing, packing, or holding of a drug product do not have the suitable to facilitate cleaning, maintenance, and proper operations.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Dr. Reddy's Laboratories2025-09-05 · US FDASimilar to finding 3 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- BayCare Integrated Service Center LLC2026-03-12 · US FDASimilar to finding 3 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- Gilead Sciences, Inc.2026-02-18 · US FDASimilar to finding 3 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- RayzeBio, Inc2026-02-24 · US FDASimilar to finding 3 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- Bentley Laboratories LLC2026-03-27 · US FDASimilar to finding 3 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
A record as of the US FDA document published on 2026-10-22. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.